ArticleScientific reports2023

Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.

Niki Karachaliou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.